Study design and methods: U.S. study to protect brain health through lifestyle intervention to reduce risk (U.S. POINTER).
Level 5 - mechanism / opinion, no new human data
Clinical trial protocol and design paper with no outcome data reported
PubMed 37776210 · doi:10.1002/alz.13365
What was done
This paper describes the design and methodology of the U.S. POINTER study, a 2-year randomized controlled trial conducted across five clinical sites. The trial is planned for 2,000 older adults at risk for dementia due to well-established risk factors. Participants are allocated to one of two multidomain lifestyle interventions covering physical exercise, diet, cognitive and social stimulation, and cardiovascular health monitoring, differing in intensity and accountability. The primary outcome is a global cognition composite measure designed to harmonize with the Finnish FINGER study, assessed at baseline and every 6 months.
What was found
No clinical outcome data or results are reported; the abstract presents only the trial rationale, design parameters, and planned methodology.
Why it matters
This study establishes the framework to test whether multidomain lifestyle interventions can be adapted to a diverse American population to protect cognitive function and reduce dementia risk.
Limits
As a trial protocol paper, it contains no efficacy, safety, or adherence data. Efficacy and feasibility cannot be evaluated until trial completion and reporting.
Cited by
- supports The FINGER trial in Finland and its US replication, the POINTER trial, evaluated multidomain lifestyle interventions comprising diet, exercise, cardiovascular risk factor monitoring and treatment, and cognitive brain training in older adults.